[{"Assets_0_Q3_USD":223801000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-26440000.0,"NetIncomeLoss_1_Q3_USD":-18699000.0,"NetIncomeLoss_3_Q3_USD":-36714000.0,"StockholdersEquity_0_Q3_USD":188114000.0,"Ticker":"TLRY","CIK":"1731348","name":"TILRAY, INC.","OfficialName":"Tilray Brands Inc. Class 2 Common Stock ","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2601094383.0","Country":"Canada","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181114"}]